Literature DB >> 4084471

Low survival of South African urban black women with cervical cancer.

A R Walker, B F Walker, D Siwedi, C Isaacson, C J Van Gelderen, A Andronikou, I Segal.   

Abstract

In Soweto, Johannesburg, the incidence of cervical cancer, the most common cancer in black women, is higher than in most white populations but lower than in many other populations. In a series of 210 patients who were diagnosed in 1981 and 1982, 50% had died within 1.6 years of diagnosis, a third of the reported survival time in white patients. The pattern of stage at presentation was similar to, although sometimes later than, those reported for various white communities. Data on patients' age at birth of first child, parity, smoking practice, and socioeconomic status, differed little from those in a control group. Neither these factors, nor availability of medical services, could be correlated with the distressingly short period of survival, which also occurs among urban black patients with breast and oesophageal cancers. Presumably, unidentified factors linked with low socioeconomic status affect survival time.

Entities:  

Mesh:

Year:  1985        PMID: 4084471     DOI: 10.1111/j.1471-0528.1985.tb04875.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  4 in total

1.  Effect of socioeconomic status on survival from cervical cancer in Sheffield.

Authors:  P C Milner; M Watts
Journal:  J Epidemiol Community Health       Date:  1987-09       Impact factor: 3.710

Review 2.  Cancer outlook: an African perspective.

Authors:  A R Walker
Journal:  J R Soc Med       Date:  1995-01       Impact factor: 5.344

3.  Age, socio-economic status and survival from cancer of cervix in the West of Scotland 1980-87.

Authors:  D W Lamont; R P Symonds; M M Brodie; N J Nwabineli; C R Gillis
Journal:  Br J Cancer       Date:  1993-02       Impact factor: 7.640

4.  Survival of cervix cancer patients in Kampala, Uganda: 1995-1997.

Authors:  H Wabinga; A V Ramanakumar; C Banura; A Luwaga; S Nambooze; D M Parkin
Journal:  Br J Cancer       Date:  2003-07-07       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.